Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Myelodysplastic Syndromes 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1Head and Neck Neoplasms 1

Interventions

GX-188 vaccine 4human papillomavirus vaccine, L1 type 16, 18 3Human Papillomavirus DNA Tests 3Colposcopy 3Blood Specimen Collection 3Vaccines 2VGX-3100 2Topotecan 2Restraint, Physical 2Paclitaxel 2Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 2Cisplatin 2Biopsy 25-aminolevulinic acid hexyl ester 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2terameprocol 1poly(gamma-glutamic acid) 1poly ICLC 1methyl 5-aminolevulinate 1epigallocatechin gallate 1artesunic acid 1artemisinin 1ZYC101a 1Watchful Waiting 1Vaccines, Synthetic 1Transurethral Resection of Prostate 1Pregnancy Tests 1Pemetrexed 1Papillomavirus Vaccines 1Ointments 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Uterine Cervical Dysplasia × terameprocol × Clear all
NCT00154089 2016-02-23

A Pilot Study of EM-1421 for the Treatment of Cervical Intraepithelial Neoplasia

Erimos Pharmaceuticals

Phase 1/2 Completed
8 enrolled
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡